According to the new market research report The “HLA typing for the transplants market” is expected to reach USD 968 million by 2025 from USD 656 million in 2019, at a CAGR of 6.7%. published by MarketsandMarkets™. The demand for transplant diagnostic products is expected to grow mainly due to factors such as the increasing public-private funding for target research activities, the growing burden of infectious diseases, the growing number of transplant procedures, and technological advancements in the field of transplant diagnostics.

Don’t miss out on business opportunities in HLA Typing Transplant Market

The demand for transplant diagnostic products for HLA typing is expected to grow mainly due to factors such as technological advancements, the growing number of diagnostic centers hospitals, increased applications in patient profiling, and rising public-private investments to support product development. These factors have prompted market players to improve and strengthen their current manufacturing and distribution capabilities—especially in emerging markets, which are expected to witness the highest growth.

HLA typing for the transplants market is categorized into diagnostic and research applications. Diagnostic applications accounted for the largest share of the HLA typing for the transplants market in 2019. Increasing adoption of molecular assay procedures for pathogen detection histocompatibility testing, and the rising incidence of chronic diseases, and supportive government regulations to increase organ donations across major healthcare markets are the key factors supporting the growth of this application segment

North America accounted for the largest share of the HLA typing for the transplants market in 2019, followed by Europe. This can primarily be attributed to the continuous commercialization of innovative transplant diagnostic products (includes HLA typing) coupled with ongoing advancements in the field of genomics and proteomics, recent discovery genetic biomarkers their clinical role in immunoassay testing, and the increasing prevalence of chronic and communicable diseases.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst